Overview of genotypic and clinical profiles of human immunodeficiency virus type 1-infected children in Rio de Janeiro, Brazil
Open Access
- 1 December 2004
- journal article
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 76 (4) , 727-741
Abstract
Although mother-to-child HIV transmission prevention has slowed down pediatric HIV infection in developed countries, large numbers of infants still become infected in developing nations. Data on pediatric HIV infection is however largely scarce. In this study, we have overviewed clinical, laboratory and genotypic data from a large cohort of HIV-infected infants regularly followed at two pediatric HIV outpatient clinics in Rio de Janeiro, Brazil. Children on antiretroviral therapy, as well as drug-naïve, newly diagnosed infants were analyzed. Prevalence of drug resistance mutations, as well as immunological and virological responses to therapy were evaluated. Additionally, HIV-1 subtype frequencies and their distribution over the course of the epidemic were studied. We have found a high prevalence of mutations among ARV-experienced children, whereas mutations were absent in the drug-naïve group. Despite the high levels of resistance among treated infants, an important improvement of their immunological status was observed. HIV-1 subtype distribution followed the trends of the adult population, with the appearance of non-B subtypes and recombinant forms after 1990. To our knowledge, this is the largest pediatric cohort ever analyzed in Brazil, and the data provided is of paramount importance to a better understanding of HIV/AIDS evolution in pediatric settings.Keywords
This publication has 56 references indexed in Scilit:
- Decrease of replicative capacity of HIV isolates after genotypic guided change of therapyJournal of Medical Virology, 2004
- Prevalence of Human Immunodeficiency Virus Drug Resistance Mutations and Subtypes in Drug-Naive, Infected Individuals in the Army Health Service of Rio de Janeiro, BrazilJournal of Clinical Microbiology, 2004
- Viral Load and CD4+ T Lymphocyte Response to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: An Observational StudyClinical Infectious Diseases, 2003
- In Vitro Hypersusceptibility of Human Immunodeficiency Virus Type 1 Subtype C Protease to LopinavirAntimicrobial Agents and Chemotherapy, 2003
- Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999The Pediatric Infectious Disease Journal, 2003
- Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of SuppressionThe Journal of Infectious Diseases, 2002
- Trends in Causes of Death among Persons with Acquired Immunodeficiency Syndrome in the Era of Highly Active Antiretroviral Therapy, San Francisco, 1994–1998The Journal of Infectious Diseases, 2002
- Effect of Highly Active Antiretroviral Therapy on Hospitalization Characteristics of HIV-Infected PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Extent of Human Immunodeficiency Virus Type 1 Drug Resistance as a Predictor of Virological Failure after Genotype‐Guided Treatment SwitchClinical Infectious Diseases, 2001
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994